<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04802200</url>
  </required_header>
  <id_info>
    <org_study_id>HAMDAN 2021</org_study_id>
    <nct_id>NCT04802200</nct_id>
  </id_info>
  <brief_title>Short-term Clinical Follow-up of the Vascular Closure Device MANTATM in Minimally Invasive Cardiac Surgery</brief_title>
  <acronym>MANTA-MICS</acronym>
  <official_title>Short-term Clinical Follow-up of the Vascular Closure Device MANTATM in Minimally Invasive Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The percutaneous MANTA Vascular Closure Device is dedicated to the closure of large bore&#xD;
      arteriotomies. It appears to be a safe and doable option for vascular access closure in&#xD;
      patients undergoing transfemoral Transcatheter Aortic Valve Implantation. Data concerning&#xD;
      safety and efficacy of MANTA Vascular Closure Device in Minimally Invasive Cardiac Surgery&#xD;
      are scarce. This study aim to assess this novel collagen-based technology in minimal invasive&#xD;
      aortic valve replacement surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Occurence of major access site vascular complications</measure>
    <time_frame>30 days</time_frame>
    <description>according to the Valve Academic Research Consortium (VARC)-2 and Bleeding Academic Research Consortium (BARC)-2 definition criteria in postoperative period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemostasis success</measure>
    <time_frame>10 min</time_frame>
    <description>Hemostasis at the puncture site of cutting the MANTA suture without need for manual or mechanical compression and without late re-bleeding</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Femoral Artery Injury</condition>
  <condition>Aortic Valve Insufficiency</condition>
  <arm_group>
    <arm_group_label>Patients operated from minimally invasive cardiac surgery</arm_group_label>
    <description>Patients operated between December 16, 2019 and june 30, 2021 from minimally invasive cardiac surgery with femoral cannulation for cardiopulmonary bypass in Dijon University hospital and in whom the MANTA device has been used for femoral artery closure</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collect</intervention_name>
    <description>Data collect following a vascular closure by MANTA</description>
    <arm_group_label>Patients operated from minimally invasive cardiac surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subject adult voluntarily agreeing to participate in the study operated between December&#xD;
        16, 2019 and june 30, 2021 from minimally invasive cardiac surgery with femoral cannulation&#xD;
        for cardiopulmonary bypass in Dijon University Hospital, in whom the MANTA device has been&#xD;
        used for femoral artery closure&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject voluntarily agreeing to participate in the study&#xD;
&#xD;
          -  Subject &gt;= 18 years of age&#xD;
&#xD;
          -  Patients operated between december 16, 2019 and june 30, 2021 from minimally invasive&#xD;
             cardiac surgery with femoral cannulation for cardiopulmonary bypass in Dijon&#xD;
             University Hospital&#xD;
&#xD;
          -  Patients in whom the MANTA device has been used for femoral artery closure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Not applicable&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Remy Hamdan</last_name>
    <phone>0380293409</phone>
    <email>remy.hamdan@chu-dijon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aline Jazayeri</last_name>
    <phone>0380281294</phone>
    <email>aline.laubriet@chu-dijon.fr</email>
  </overall_contact_backup>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>March 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2021</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

